Enteralia Bioscience SRL Acquires TFarma SRL
Enteralia Bioscience SRL Acquires TFarma to Strengthen Presence in Italy's Nutraceutical and Medical Device Market
MILAN, ITALY / ACCESSWIRE / November 7, 2024 / Enteralia Bioscience SRL ("Enteralia") is pleased to announce the acquisition of TFarma, a well-established company focused on the sales and marketing of nutraceuticals and medical devices in Italy. This strategic acquisition marks a key milestone in Enteralia's expansion within the Italian market, one of Europe's largest and most influential sectors.
Through this acquisition, Enteralia gains direct access to an established network of over 20 Medical Representatives and Area Managers, who are known for their expertise in the gynecological and gastroenterological fields. The integration of TFarma's product portfolio, which has a strong and consistent revenue track record, will further bolster Enteralia's growth trajectory.
Looking ahead, Enteralia plans to expand its sales network and territorial reach, supported by the introduction of new products from the pipeline of Nemysis Limited, its parent company. These investments are expected to drive substantial revenue and profit growth in the near term.
In addition to expanding the product portfolio, Enteralia is committed to investing in TFarma's existing team, recognizing the critical role they play in the company's success.
"We are delighted to welcome TFarma and its team into the Enteralia family, accelerating our future growth and strengthening our position in the Italian market. The synergy between our product lines, and the experience of TFarma's team, reinforce our strategy and ability to accomplish increasingly ambitious growth" said Antonio Maggi, CEO of Enteralia Bioscience SRL.
Dr. Claudio Ciani and Dr. Giuseppe Giuliani, founding partners of TFarma, shared, "After nearly 20 years since TFarma's founding, we are excited to join Enteralia and its team as we enter a new phase of growth. Our shared focus on women's health and gastroenterology, combined with Enteralia's significant investment in our team and new products from their pipeline, makes Enteralia an ideal partner for our future."
About Enteralia Bioscience SRL
Enteralia Bioscience SRL is an Italian pharmaceutical company and part of the Nemysis Limited group. Its mission is to promote innovative research products from Nemysis, targeting professionals in gynecology and gastroenterology. Enteralia aims to provide effective solutions for prevalent health issues, including iron deficiency, with or without anemia.
About TFarma
TFarma SRL is an Italian pharmaceutical company with a 20-year presence in the gynecological and gastroenterological therapeutic areas. Known for its innovative and effective solutions, TFarma focuses on products that enhance women's health and manage gastroenterological disorders.
Contact Information
Antonio Maggi
Amministratore Delegato
a.maggi@enteralia.it
0280862072
SOURCE: Enteralia Bioscience Srl
View the original press release on newswire.com.
Enteralia Bioscience S.r.l
Subscribe to releases from ACCESSWIRE
Subscribe to all the latest releases from ACCESSWIRE by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESSWIRE
Mailbird Expands to Mac: Popular Windows Email Client Launches Much-Anticipated Mac App20.11.2024 08:00:00 EET | Press release
Email management is about to get easier for Apple users. SACRAMENTO, CA / ACCESSWIRE / November 20, 2024 / Mailbird, the email client trusted by millions of Windows users worldwide, is now available for Mac. After years of user anticipation, Mailbird's Mac app brings the same clutter-free simplicity and clean design language to Apple fans.Mailbird for Mac Mailbird for Mac "The launching of Mailbird for Mac marks a truly significant point in our company vision," said Alexis Dollé, Head of Growth at Mailbird. "Although we originally designed Mailbird for Windows, we always envisioned presenting our customers with a cross-platform app so they can enjoy a unified email experience no matter where they are. Mailbird for Mac is the first step towards achieving that goal." Focusing on customers' needs is nothing new to Mailbird. With user-favorite features-unified inbox, email tracking, third-party app integrations, advanced search capabilities, folders, and email signatures-Mailbird for Mac p
Linacre Investments Temporarily Caps the Digital Asset Innovation Fund20.11.2024 08:00:00 EET | Press release
Linacre Investments Limited, a leading institutional fund manager headquartered in the Isle of Man, has announced a $1 billion cap on its Digital Asset Innovation Fund. The decision comes in response to exceptional demand during the second half of 2024 and aims to ensure effective liquidity management. LONDON, UNITED KINGDOM / ACCESSWIRE / November 20, 2024 / The fund was designed to seize emerging opportunities within the rapidly growing digital asset sector by focusing on digital assets and blockchain-based companies driving innovation. It offers institutional and accredited high-net-worth investors a unique chance to leverage the transformative potential of these technologies. Over the past six months, the fund has experienced extraordinary demand, fueled by the increasing mainstream adoption of digital assets, recent regulatory advancements such as ETF approvals, and the momentum generated by the recent U.S. elections. Over the past twelve months, the Digital Asset Innovation Fund
Ciavarella Pneumatici Selects ToolsGroup to Revolutionize Supply Chain Planning19.11.2024 08:00:00 EET | Press release
Leading Italian Tire Distributor Aims to Enhance Demand Forecasting, Inventory Management, and Customer Service MILAN, ITALY and BOSTON, MA / ACCESSWIRE / November 19, 2024 / ToolsGroup, a global leader in retail and supply chain planning and optimization software, has been chosen by Ciavarella Pneumatici, one of Italy's premier B2B tire distributors, to enhance its supply chain planning processes. This strategic partnership aims to improve demand planning efficiency, optimize inventory performance, and elevate service levels. Ciavarella Pneumatici has established itself as a cornerstone in the Italian tire distribution landscape, serving the B2B market with distinction. The company's dynamic approach and commitment to innovation have fueled its expansion to five strategically located warehouses, enabling comprehensive coverage of Central and Southern Italy. Ciavarella's efficient distribution system, coupled with a highly qualified staff, allows for rapid and punctual delivery, settin
Gran Fondo de Ciclismo de Bogotá: Boosting the Local Economy and Creating Jobs17.11.2024 03:00:00 EET | Press release
Bogotá will host one of the most anticipated sports events of the year: the Gran Fondo Bogotá x Egan. BOGOTÁ, COLOMBIA / ACCESSWIRE / November 17, 2024 / On November 17, Bogotá will host one of the most anticipated sports events of the year: the Gran Fondo de Ciclismo de Bogotá. This celebration of cycling will not only showcase the spirit of the sport but will also generate a significant economic and social benefit in the city, boosting local small and medium-sized businesses as well as the tourism and hospitality sectors. Invitation banner Gran Fondo de Ciclismo de Bogotá. Supporting the Local Economy The Gran Fondo de Ciclismo de Bogotá is making a significant contribution, injecting an impressive $3 billion COP (more than €640,000) into the local economy. This investment directly engages 42 Bogotá-based companies providing essential goods and services, many of them small businesses located in the neighborhoods along the race route. This translates into direct economic growth within
Polaris Renewable Energy Successfully Places USD 175 Million Bond Issue15.11.2024 12:00:00 EET | Press release
TORONTO, ON / ACCESSWIRE / November 15, 2024 / Polaris Renewable Energy Inc. (TSX:PIF) ("Polaris" or the "Company") announces that it has successfully completed a private placement of USD 175 million senior secured green bonds. The bonds will have a tenor of five years and a fixed coupon rate of 9.5% percent per annum, with interest payable in semi-annual instalments. The bond issue is rated BB- by S&P Global Ratings and is issued under the Company's green finance framework with second-party opinion from Morningstar Sustainalytics. Marc Murnaghan, Chief Executive Officer of Polaris comments: "We are very pleased to successfully place Polaris' inaugural bond issue with strong interest from a wide set of international investors. The bond optimizes the Company's capital structure and secures financing for further growth and increased diversification of cash flow." Settlement of the bonds is expected to occur on or around December 3, 2024, subject to the satisfaction of customary condition
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom